Factor VIII/IX claims will not be pursued by federal insurers, according to DoJ/defendants agreement.

Executive Summary

FACTOR VIII/IX CLAIMS BY FEDERAL INSURERS WILL NOT BE PURSUED, according to an April 30 letter from the defendants in the hemophilia/HIV class action suit to Chicago federal court Judge John Grady. The Department of Justice, which represented federal insurance programs, is accepting the payment of the $640 mil. settlement to hemophilia patients who received HIV-tainted blood ("The Pink Sheet" March 24, p. 11). The government insurers, which may have paid for some of the treatments, will not seek to recover money from the settlements.